|
Interferon infiltration of the inoculation site Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 3: 1
Top Sponsors
- BriaCell Therapeutics Corporation1
Indications
- End Stage Cancer1
- Metastatic Breast Cancer1
- Breast Cancer, Metastatic1
- Breast Neoplasm1
- Breast Cancer1
Phoenix, Arizona1 trial
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Mayo Clinic-Comprehensive Cancer Center-Breast Clinic
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.